Phase II trial of topotecan, carboplatin, and paclitaxel as front-line therapy in suboptimal advanced epithelial ovarian cancer

Citation
G. Bolis et al., Phase II trial of topotecan, carboplatin, and paclitaxel as front-line therapy in suboptimal advanced epithelial ovarian cancer, GYNECOL ONC, 81(2), 2001, pp. 331-333
Citations number
6
Categorie Soggetti
Reproductive Medicine
Journal title
GYNECOLOGIC ONCOLOGY
ISSN journal
00908258 → ACNP
Volume
81
Issue
2
Year of publication
2001
Pages
331 - 333
Database
ISI
SICI code
0090-8258(200105)81:2<331:PITOTC>2.0.ZU;2-Z